Clinical Trial Update: Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the efficacy and safety of Miconazole Lauriad for treating oropharyngeal candidiasis in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Candidiasis

Drugs mentioned

• Miconazole Lauriad (miconazole mucoadhesive lozenge)

Snippet

Sponsor: Valerio Therapeutics | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-08-29